How to applyEligibility criteriaThe project must concern a biotherapy or bioproduction approach in health linked to at least one of the following 3 thematic axes of the DIM BioConvS:
Complete the DIM BioConvS membership form The acquisition must take place within 18 months following the financing decision (i.e. no later than July 31, 2025).
Selection criteriaApart from the scientific quality of the project, the evaluation will take into account the strategic nature of the equipment, its sharing and the involvement of young researchers and emerging teams. Collaborative or platform projects will be given priority. Projects encouraging the association of a socio-economic partner are encouraged. Priority will also be given to establishments that have not received DIM BioConvS funding in 2023. List of documents that must be included in each file
Please note: The co-financing letter must be signed by the legal representative of the purchasing organization. The signature of the laboratory director will not be accepted.
Characteristics of the fundingTeams receiving support from DIM BioConvS will de facto be part of the DIM BioConvS network. Thus, the Île-de-France Region encourages its members to submit their publications on open access platforms (HAL, etc.).
Eligible expensesEquipment whose total cost is greater than €7,500 excluding tax is eligible. Shipping, installation and training costs as well as maintenance may be eligible if this information appears clearly on the initial quote and therefore if these services are covered directly by the supplier. Computers and software are also eligible if they are essential to the operation of the equipment.
Co-financingEvery DIM’s equipment funding come with a clause of a minimum co-funding of 34%. It means that, of the total expense of equipment that you buy (could be multiple equipments belonging to the same platform), at least 34% of the total price (HT) has to be financed by another source of funding than this call. The source of funding could be your institute, or any other grant you want that is not coming from Région Ile-de-France. Please note that any discount from the manufacturer is not counted as co-financement. Please check the FAQ for more details. CommitmentThe beneficiary undertakes to cite the Île-de-France Region and the DIM BioConvergence for Health in any publication where experiments were carried out using the purchased equipment, by adding the following wording to the acknowledgments section:
Communication obligationsThe Region's logo must appear on all information and communication and/or event media relating to the supported project, whether printed, digital or audiovisual.
Management of GDPR dataDIM BioConvS undertakes to comply with the General Data Protection Regulation (GDPR), i.e. all the rules relating to the protection of individuals with regard to the processing of personal data , the free movement of this data and the right to the protection of this data.
|
Online user: 2 | Privacy |